Back

Non-invasive rejection surveillance in stable heart transplantation using local laboratory-run donor-derived cell-free DNA assay: two-centre European feasibility study

27 August 2023 (14:15 - 14:45)
Organised by: Logo
Congress Presentation Part of: Advanced heart failure therapies: transplant and MCS Heart Transplantation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Timea Teszak

Semmelweis University, Budapest (Hungary)

5 More presentations in this session

Presentation thumbnail
Predictors on admission associated with successful weaning and in - hospital mortality in patients with refractory shock undergoing veno - arterial extracorporeal membrane oxygenation
Associate Professor J. Hong (Anyang-Si- Gyeonggi-Do, KR)
Abstract Slides Video
Presentation thumbnail
Outcomes of pediatric ventricular assist device in the United States: an analysis of the national inpatient sample database
Doctor M. Hamzah (Doha, QA)
Abstract Slides Video
Presentation thumbnail
Clinical relevance and outcome of routine endomyocardial biopsy to detect rejection after heart transplantation
Doctor M. Oerlemans (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Elevated lipoprotein a level in heart transplant patients is associated with cardiac allograft vasculopathy
Mr D. Enriquez Vazquez (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Predictors and outcomes of rejection requiring treatment within the first year following heart transplantation
Doctor A. Briasoulis (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Advanced heart failure therapies: transplant and MCS

The Event

Event poster

ESC Congress 2023

27 August 2023 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Decentralized donor-derived cell-free DNA testing for cardiac allograft rejection: clinical validation and additive value beyond standard-of-care monitoring
thumbnail
Congress Presentation
Donor-derived cell-free DNA as a new biomarker for acute rejection in heart transplant recipients: results from the freedna car study
thumbnail
Congress Presentation
Improvements in post-HTx care for better long-term outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources